The costs and benefits of vaccinating troops on United Nations tours in Yugoslavia against hepatitis A were compared.
The marginal cost of one case of hepatitis A avoided by vaccination was calculated and compared with the marginal cost of achieving the same outcome by passive immunization.
The cost-benefit ratio (medium estimate) for troops at low risk of contracting hepatitis A was 0.01 and for those at high risk was 0.03.
Vaccinating troops against hepatitis A for a single deployment appears to be an inefficient procedure, especially in troops at low risk.
However, in professional troops from countries of low hepatitis A endemicity who are likely to be involved in several operational deployments, vaccination becomes more efficient the more times the same troops are deployed.
Mots-clés Pascal : Hépatite virale A, Virose, Infection, Vaccination, Analyse avantage coût, Economie santé, Analyse coût efficacité, ONU, Militaire, Prévention, Programme sanitaire, Yougoslavie, Europe, Homme, Appareil digestif pathologie, Foie pathologie
Mots-clés Pascal anglais : Viral hepatitis A, Viral disease, Infection, Vaccination, Cost benefit analysis, Health economy, Cost efficiency analysis, UNO, Military, Prevention, Sanitary program, Yugoslavia, Europe, Human, Digestive diseases, Hepatic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0591827
Code Inist : 002B05C02G. Création : 09/06/1995.